Literature DB >> 2653242

Synovial fluid phospholipase A2s and inflammation.

H Gonzalez-Buritica1, M A Khamashita, G R Hughes.   

Abstract

The activation of phospholipase A2 is believed to have an important role in the inflammatory process owing to its induction of eicosanoids, platelet activating factor, and other mediators. Soluble phospholipase A2 has been associated with exudates in different inflammatory conditions. In this review the general physiology and control of this enzyme and, in particular, the most recent findings on human synovial fluid phospholipase A2s are discussed.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2653242      PMCID： PMC1003739          DOI： 10.1136/ard.48.4.267

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  21 in total

Review 1.  Role of secretory phospholipases A2 in the pathobiology of disease.

Authors:  P Vadas; W Pruzanski
Journal:  Lab Invest       Date:  1986-10       Impact factor: 5.662

2.  On the mechanism of the biosynthesis of prostaglandins E-1 and F-1-alpha.

Authors:  M Hamberg; B Samuelsson
Journal:  J Biol Chem       Date:  1967-11-25       Impact factor: 5.157

3.  Phospholipase A2 activity associated with synovial fluid cells.

Authors:  W Pruzanski; P Vadas; J Kim; H Jacobs; E Stefanski
Journal:  J Rheumatol       Date:  1988       Impact factor: 4.666

4.  Inflammatory effect of intradermal administration of soluble phospholipase A2 in rabbits.

Authors:  W Pruzanski; P Vadas; V Fornasier
Journal:  J Invest Dermatol       Date:  1986-04       Impact factor: 8.551

5.  Interleukin 1 activates phospholipase A2 in rabbit chondrocytes: a possible signal for IL 1 action.

Authors:  J Chang; S C Gilman; A J Lewis
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

6.  Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme.

Authors:  W Pruzanski; P Vadas; E Stefanski; M B Urowitz
Journal:  J Rheumatol       Date:  1985-04       Impact factor: 4.666

7.  Enhanced phospholipase activity in peripheral blood monocytes from patients with rheumatoid arthritis.

Authors:  J S Bomalaski; M A Clark; R B Zurier
Journal:  Arthritis Rheum       Date:  1986-03

8.  Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.

Authors:  F F Davidson; E A Dennis; M Powell; J R Glenney
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

9.  Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid.

Authors:  P Vadas; E Stefanski; W Pruzanski
Journal:  Life Sci       Date:  1985-02-11       Impact factor: 5.037

10.  Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets.

Authors:  M Hamberg; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205
View more
  2 in total

1.  Phospholipase A2 and inflammation.

Authors:  W Pruzanski; P Vadas
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

2.  EP4 receptor regulates collagen type-I, MMP-1, and MMP-3 gene expression in human tendon fibroblasts in response to IL-1 beta treatment.

Authors:  Bhavani P Thampatty; Hongxia Li; Hee-Jeong Im; James H-C Wang
Journal:  Gene       Date:  2006-09-15       Impact factor: 3.688
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.